Efficacy and Safety of LSD in the treatment of mental and substance use disorders: A systematic review of randomized controlled trials
- 5 July 2025
- journal article
- review article
- Published by Elsevier in Psychiatry Research
- Vol. 351, 116622
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Greater subjective effects of a low dose of LSD in participants with depressed moodNeuropsychopharmacology, 2023
- Lysergic Acid Diethylamide–Assisted Therapy in Patients With Anxiety With and Without a Life-Threatening Illness: A Randomized, Double-Blind, Placebo-Controlled Phase II StudyBiological Psychiatry, 2022
- Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019The Lancet Psychiatry, 2022
- Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participantsPsychopharmacology, 2021
- Explaining heterogeneity in meta-analysis: a comparison of methodsStatistics in Medicine, 1999
- How LSD OriginatedJournal of Psychedelic Drugs, 1979
- Residential Psychedelic (LSD) Therapy for the Narcotic AddictArchives of General Psychiatry, 1973
- Psychedelic (LSD) Therapy of Neurotic Disorders: Short-Term EffectsJournal of Psychedelic Drugs, 1972
- LSD in the Treatment of Alcoholics*Pharmacopsychiatry, 1971
- The Experimental Use of Psychedelic (LSD) PsychotherapyJAMA, 1970